• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SMITH & NEPHEW ORTHOPAEDICS LTD ACETABULAR CUP HAP SIZE 52/58; PROSTHESIS, HIP, SEMI-CONSTRAINED, METAL/METAL, RESURFACING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SMITH & NEPHEW ORTHOPAEDICS LTD ACETABULAR CUP HAP SIZE 52/58; PROSTHESIS, HIP, SEMI-CONSTRAINED, METAL/METAL, RESURFACING Back to Search Results
Model Number 74122158
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Code Medical device site infection (4845)
Date of Event 07/06/2022
Type of Reportable Event Serious Injury
Event or Problem Description
Us legal it was reported that, after a right bhr resurfacing construct had been implanted on the patient¿s right hip on (b)(6) 2010 due to osteoarthritis, the patient experienced an infection.A two-stage revision surgery was performed to address this complication.First stage performed on (b)(6) 2022.During this procedure, the resurfacing head and cup were explanted.Intraoperatively, a gross purulence was identified upon opening the capsule.The wound was thoroughly debrided, and an antibiotic spacer was placed.The procedure went uneventful, and the patient was transfer to recovery room in stable condition.Second stage revision surgery date is unknown.
 
Additional Manufacturer Narrative
Internal reference: (b)(4).
 
Additional Manufacturer Narrative
H3, h6.It was reported that a two-stage revision surgery was performed to address an infection after a right bhr resurfacing construct was implanted.As of today, the implanted devices, all of which were used in treatment have not been returned for evaluation.A review of the historical complaints data for the devices concerned was performed using batch numbers, part numbers and the reported failure modes to evaluate patterns of repeated failures or defects.Similar complaints have been identified for the head, and this failure will continue to be monitored.In the absence of the actual devices, the production records were reviewed for the devices reportedly involved in this incident.All released devices involved met manufacturing specifications upon release for distribution.The review of the product ifu found adequate warnings and precautions in relation to the alleged failure modes.A risk management review was performed.The alleged failure modes and associated risks have been anticipated within the risk file and the anticipated risk level is still adequate.No further actions are required at this time.A review of historic escalation actions related to the products and similar complaint events was performed.Following the review, no prior applicable escalation actions were identified.The available medical documents were reviewed.Although a joint infection and subsequent two-stage revision was reported, the clinical root cause of the infection cannot be confirmed; however, the reported infection is highly likely of an exogenous nature.It cannot be concluded the reported infection was associated with a mal performance of the implant or implant failure.The patient impact beyond the joint infection, and two-stage revision cannot be determined with the limited information provided.Based on the information provided, further investigation of the reported complaint cannot be carried out and remains inconclusive.A definitive root cause cannot be determined.Based on the limited information provided we are unable to speculate on specific factors known to contribute to the alleged fault.Should the devices or additional information be received, the complaint will be reopened.Based on this investigation, the need for corrective and preventative actions is not indicated.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ACETABULAR CUP HAP SIZE 52/58
Common Device Name
PROSTHESIS, HIP, SEMI-CONSTRAINED, METAL/METAL, RESURFACING
Manufacturer (Section D)
SMITH & NEPHEW ORTHOPAEDICS LTD
aurora house, spa park
leamington spa warwickshire CV31 3HL
UK  CV31 3HL
Manufacturer (Section G)
SMITH & NEPHEW ORTHOPAEDICS LTD
aurora house, spa park
leamington spa warwickshire CV31 3HL
UK   CV31 3HL
Manufacturer Contact
holly topping
7000 west william cannon drive
austin, TX 78735
5123913905
MDR Report Key16862760
Report Number3005975929-2023-00058
Device Sequence Number20282661
Product Code NXT
UDI-Device Identifier03596010552310
UDI-Public03596010552310
Combination Product (Y/N)N
Initial Reporter CountryUS
PMA/510(K) Number
P040033
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2010
Device Explanted Year2022
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Other,Consumer
Initial Reporter Occupation Other
Type of Report Initial,Followup
Report Date (Section B) 06/06/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Model Number74122158
Device Catalogue Number74122158
Device Lot Number10AW25647
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 04/19/2023
Supplement Date Received by Manufacturer06/06/2023
Initial Report FDA Received Date05/03/2023
Supplement Report FDA Received Date06/06/2023
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Is the Device Labeled for Single Use? (Y/N) Yes
Usage of Device A
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
PN: 74123152 / LOT: 10CW25932
Outcome Attributed to Adverse Event Other;
Patient Age66 YR
Patient SexMale
-
-